Human Heterogeneous Nuclear Ribonucleoprotein K Antibody from EXALPHA BIOLOGICALS, INC.
Search, find, compare suppliers for anti-Human Heterogeneous Nuclear Ribonucleoprotein K antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human Heterogeneous Nuclear Ribonucleoprotein K |
| Clone | F45 P9 C7 |
| Host Species | Mouse |
| Reactive Species | human, mouse, rat, rabbit, chicken |
| Isotype | IgG1 |
| Format | Protein A/G purified |
| Size | 200 µg |
| Concentration | n/a |
| Applications | Western Blotting, Western Blotting, Immunohistochemistry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Mouse anti Human Heterogeneous Nuclear Ribonucleoprotein K |
| Immunogen | Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the C-terminal of the hnRNP-K protein and mouse myeloma Ag8563 cells. Sequence common in human, mouse, rat, rabbit and chicken |
| Other Names | hnRNP-K; CSBP; TUNP; dC-Stretch Binding Protein |
| Gene, Accession # | UniProt: P61978 |
| Catalog # | X2068M |
| Price | $319 |
| Order / More Info | Human Heterogeneous Nuclear Ribonucleoprotein K Antibody from EXALPHA BIOLOGICALS, INC. |
| Product Specific References | 1. Wei, C.C., et al. (2006). Heterogeneous nuclear ribonucleoprotein K modulates angiotensinogen gene expression in kidney cells. J. Biol. Chem. 281(35):25344-25355 2. Dzwonek, A., et al. (2006). The diverse involvement of heterogeneous nuclear ribonucleoprotein K in mitochondrial response to insulin. FEBS Lett. 580(7):1839-1845 3. Carpenter, B., et al. (2006). Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br. J. Cancer. 95(7):921-927 |
EXALPHA BIOLOGICALS, INC.
EXALPHA BIOLOGICALS, INC.
2 Shaker Road, Unit B101
Shirley MA 01464
P: 978-425-1370
info@exalpha.com
https://www.exalpha.com
Profile of EXALPHA BIOLOGICALS, INC.
Return to Antibodies